A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia
- PMID: 16326074
- DOI: 10.1016/j.schres.2005.10.001
A 12-week, randomized, open-label, parallel-group trial of topiramate in limiting weight gain during olanzapine treatment in patients with schizophrenia
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
